Byoung S. Ye

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 156 publications

Cerebral Perfusion and Motor Deficits in Drug-Induced Parkinsonism: A Dual-Phase 18F-FP-CIT PET Study.

Cerebral Perfusion and Motor Deficits in Drug-Induced Parkinsonism: A Dual-Phase 18F-FP-CIT PET Study.

Journal: Neurology

Published: January 09, 2026

Deep learning for FDG-PET classification in patients with Alzheimer's disease, dementia with Lewy bodies and their mixed pathology: a solution for diagnostic heterogeneity.

Deep learning for FDG-PET classification in patients with Alzheimer's disease, dementia with Lewy bodies and their mixed pathology: a solution for diagnostic heterogeneity.

Journal: Frontiers in aging neuroscience

Published: January 05, 2026

Effect of tau burden and Lewy pathology on neuropsychiatric symptoms in Aβ-positive individuals.

Effect of tau burden and Lewy pathology on neuropsychiatric symptoms in Aβ-positive individuals.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: October 14, 2025

Comparative evaluation of automated MRI-based brain volumetry software for estimating cognitive domains in early Alzheimer's disease.

Comparative evaluation of automated MRI-based brain volumetry software for estimating cognitive domains in early Alzheimer's disease.

Journal: BMC medical imaging

Published: September 05, 2025

Association between masticatory function and cognitive ability in mild cognitive impairment.

Association between masticatory function and cognitive ability in mild cognitive impairment.

Journal: BMC geriatrics

Published: August 05, 2025

Local gyrification index and sulcal depth as imaging markers of cognitive decline in Alzheimer's disease.

Local gyrification index and sulcal depth as imaging markers of cognitive decline in Alzheimer's disease.

Journal: Frontiers in aging neuroscience

Published: May 27, 2025

Degenerative pathologies on cortical biopsy, dopaminergic depletion, and shunt efficacy in iNPH.

Degenerative pathologies on cortical biopsy, dopaminergic depletion, and shunt efficacy in iNPH.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: April 25, 2025

Clinical Implications of an Integrated Clinical and Biological Staging Scheme for Alzheimer's Disease.

Clinical Implications of an Integrated Clinical and Biological Staging Scheme for Alzheimer's Disease.

Journal: Journal of clinical neurology (Seoul, Korea)

Published: April 25, 2025

Putaminal hypermetabolism identifies Lewy body co-pathology in Alzheimer's disease.

Putaminal hypermetabolism identifies Lewy body co-pathology in Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: April 03, 2025

A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders.

A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders.

Journal: Nature medicine

Published: March 21, 2025

Implication of dopamine transporter and electroencephalography biomarkers in dementia with lewy bodies.

Implication of dopamine transporter and electroencephalography biomarkers in dementia with lewy bodies.

Journal: Scientific reports

Published: March 03, 2025

Impact of statins on mortality and disease progression in patients with Alzheimer's disease: a nationwide cohort study.

Impact of statins on mortality and disease progression in patients with Alzheimer's disease: a nationwide cohort study.

Journal: Frontiers in neuroendocrinology

Published: February 06, 2025

Showing 1-12 of 156

Last Updated: 09/26/2026